What Sonoma Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Dvonch Jerome J | Chief Financial Officer | Jun 20 | Grant / award · A | +53,586 | — | — | 84,595 |
| Trombly Amy Moss | Chief Executive Officer | Jun 20 | Grant / award · A | +53,586 | — | — | 153,586 |
| Dal Poggetto John | Controller | Jun 20 | Grant / award · A | +15,000 | — | — | 15,000 |
| Thornton Bruce | Executive Vice President | Jun 20 | Grant / award · A | +53,586 | — | — | 154,411 |
| Trombly Amy Moss | Chief Executive Officer | Jun 30 | Grant / award · A | +100,000 | — | — | 213,648 |
| Thornton Bruce | Executive Vice President | Jun 30 | Grant / award · A | +100,000 | — | — | 216,781 |
| Dal Poggetto John | Chief Financial Officer | Apr 23 | Grant / award · A | +3,086 | — | — | 3,201 |
| Edwards Robert Grant | Chief Financial Officer | Apr 23 | Grant / award · A | +2,609 | — | — | 2,609 |
| Mclaughlin John | Director | May 30 | Grant / award · A | +1,781 | — | — | 48,728 |
| Harrison Russell Joseph | Director | May 30 | Grant / award · A | +1,538 | — | — | 46,520 |
| Birnbaum Jay E | Director | May 30 | Grant / award · A | +1,052 | — | — | 51,659 |
| Miller Robert E | Chief Financial Officer | Mar 13 | Open-market buy · P | +1,200 | $4.10 | +$4.92K | 18,868 |
| Miller Robert E | Chief Financial Officer | Mar 12 | Open-market buy · P | +1,200 | $4.03 | +$4.84K | 17,668 |
| Miller Robert E | Chief Financial Officer | Mar 12 | Open-market buy · P | +1,200 | $4.03 | +$4.84K | 16,468 |
| Miller Robert E | Chief Financial Officer | Mar 09 | Open-market buy · P | +1,200 | $3.90 | +$4.68K | 15,268 |
| Schutz James J | Chief Executive Officer | Mar 08 | Open-market buy · P | +2,473 | $3.99 | +$9.87K | 35,858 |
| Mclaughlin John | Director | Mar 01 | Grant / award · A | +1,958 | — | — | 46,947 |
| Birnbaum Jay E | Director | Mar 01 | Grant / award · A | +1,157 | — | — | 50,607 |
| Harrison Russell Joseph | Director | Mar 01 | Grant / award · A | +1,691 | — | — | 44,982 |
| Barbari Sharon Surrey | Director | Mar 01 | Grant / award · A | +1,424 | — | — | 43,417 |
Loading...
